Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer
- 21 October 2004
- journal article
- clinical trial
- Published by Wiley in Journal of Surgical Oncology
- Vol. 88 (2), 78-85
- https://doi.org/10.1002/jso.20141
Abstract
Purpose Selective internal radiation therapy (SIRT) with SIR‐Spheres® is a new technique for selectively targeting high doses of radiation to tumours within the liver. The primary objectives of this randomised trial were to compare the response rate, time to progressive disease (PD), and toxicity of a regimen of systemic fluorouracil/leucovorin chemotherapy versus the same chemotherapy plus a single administration of SIR‐Spheres in patients with advanced colorectal liver metastases. The trial was designed to presage a larger trial that would have survival as the primary outcome. Patients and Methods Twenty‐one patients with previously untreated advanced colorectal liver metastases, with or without extrahepatic metastases, were randomised into the study. Results Using RECIST criteria, the response rate for 11 patients receiving the combination treatment was significantly greater than for 10 patients receiving chemotherapy alone (First Integrated Response; 10 PR, 1 SD vs. 0 PR, 6 SD, 4 PD, P < 0.001 and Best Confirmed Response; 8 PR, 3 SD vs. 0 PR, 6 SD, 4 PD P < 0.001). The time to PD was greater for patients receiving the combination treatment (18.6 months vs. 3.6 months, P < 0.0005). Median survival was significantly longer for patients receiving the combination treatment (29.4 months vs. 12.8 months, P = 0.02). One patient in the combination arm died from chemotherapy induced neutropenic sepsis after the fourth chemotherapy cycle. There were more Grade 3 and 4 toxicity events in patients receiving the combination treatment. There was no difference in quality‐of‐life over a 3 month period between the two treatments when rated by patients (P = 0.96) or physicians (P = 0.98). Conclusions This small phase 2 randomised trial demonstrated that the addition of a single administration of SIR‐Spheres to a regimen of systemic fluorouracil/leucovorin chemotherapy significantly increased both treatment related response, time to PD, and survival with acceptable toxicity. The combination of SIR‐Spheres plus systemic chemotherapy is now the subject of ongoing trials to further define patient benefit. J. Surg. Oncol. 2004;88:78–85.Keywords
This publication has 24 references indexed in Scilit:
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- REGRESSION OF LIVER METASTASES FOLLOWING TREATMENT WITH YTTRIUM‐90 MICROSPHERESAnz Journal of Surgery, 1992
- Selective internal radiation (SIR) therapy for treatment of liver metastases: Measurement of response rateJournal of Surgical Oncology, 1989
- Selective internal radiation therapy: Distribution of radiation in the liverEuropean Journal of Cancer and Clinical Oncology, 1989
- Vascularization of small liver metastasesBritish Journal of Surgery, 1989
- Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Sites of recurrent tumour after ‘curative’ colorectal surgery: Implications for adjuvant therapyBritish Journal of Surgery, 1984
- Hepatic metastases—a physiological approach to treatmentBritish Journal of Surgery, 1983
- Measuring the quality of life of cancer patients: A concise QL-Index for use by physiciansJournal of Chronic Diseases, 1981